نتایج جستجو برای: ion therapy

تعداد نتایج: 854184  

Journal: :Physics in medicine and biology 2017
Christian P Karger Peter Peschke

Carbon ion therapy is a promising evolving modality in radiotherapy to treat tumors that are radioresistant against photon treatments. As carbon ions are more effective in normal and tumor tissue, the relative biological effectiveness (RBE) has to be calculated by bio-mathematical models and has to be considered in the dose prescription. This review (i) introduces the concept of the RBE and its...

2012

Charged-particle beams consisting of protons or helium ions are a type of particulate radiation therapy. They contrast with conventional electromagnetic (i.e., photon) radiation therapy due to several unique properties including minimal scatter as particulate beams pass through tissue, and deposition of ionizing energy at precise depths (i.e., the Bragg peak). Thus, radiation exposure of surrou...

2013

Charged-particle beams consisting of protons or helium ions are a type of particulate radiation therapy. They contrast with conventional electromagnetic (i.e., photon) radiation therapy due to several unique properties including minimal scatter as particulate beams pass through tissue, and deposition of ionizing energy at precise depths (i.e., the Bragg peak). Thus, radiation exposure of surrou...

Journal: :Journal of radiation research 2010
Nobuyuki Hamada Tatsuhiko Imaoka Shin-ichiro Masunaga Toshiyuki Ogata Ryuichi Okayasu Akihisa Takahashi Takamitsu A Kato Yasuhiko Kobayashi Takeo Ohnishi Koji Ono Yoshiya Shimada Teruki Teshima

Superb biological effectiveness and dose conformity represent a rationale for heavy-ion therapy, which has thus far achieved good cancer controllability while sparing critical normal organs. Immediately after irradiation, heavy ions produce dense ionization along their trajectories, cause irreparable clustered DNA damage, and alter cellular ultrastructure. These ions, as a consequence, inactiva...

Journal: :Journal of Instrumentation 2023

Abstract The proton-boron aneutronic fusion reaction has numerous potential applications varying from controlled nuclear reactor to broad-energy spectrum α-particle source, as well uses in medicine, where it can serve a source for radioisotope production, or directly proton boron capture therapy. However, and its by-products should be investigated extensively provide stable secondary ion source...

Journal: :iranian journal of chemistry and chemical engineering (ijcce) 2000
hassan khodakarami hedayat o. ghourchian

a pvc-based membrane containing cerium phosphate was developed. unlike the cerium phosphate itself that acts as a cation exchanger, the membrane exhibited anion-exchange properties. therefore, the utility of this compound as a sensory element for detection of molybdate ions was pursued. the response of molybdate selective electrode based on this membrane was perfectly linear in the concentratio...

Journal: :journal of physical & theoretical chemistry 2005
m. aghaie f. ghaemi amiri m. giahi

using the evaporating method, the solubility of potassium nitrate was determined in various mixtures containing water and ethanol at 25°c. the results show that the solubility of kno3 decreases with increasing the mass percent of ethanol in the mixtures. this trend is along with decreasing the dielectric constant of water+ethanol mixtures. moreover, it can be concluded that the totqal solubilit...

2017
Eleanor Blakely Takashi Shimokawa

The main purpose of this meeting was to discuss radiation biology implications and issues for the design of light ion particle therapy (LIBT) clinical trials. This is a sequence of IAEA’s Consultant Meeting on Particle Therapy in the 21 Century, held in November 2014, on which the IAEA report “Particle Therapy in the 21 Century: Relevance to Developing Countries” was based. Light ion therapy (L...

2015
K. Peach J. Cobb S. L. Sheehy H. Witte T. Yokoi

The status of PAMELA (Particle Accelerator for MEdical Applications) – an accelerator for proton and light ion therapy using a non-scaling FFAG (ns-FFAG) accelerator – is reviewed and discussed.

Journal: :Cancer research 1975
C Fenselau M N Kan S Billets M Colvin

An active metabolite of cyclophosphamide, N,N-bis(2-chloroethyl)phosphorodiamidic acid, has been confirmed as a circulating and excreted metabolite in patients receiving the drug in therapy, by selected ion monitoring on a gas chromatograph mass spectrometer.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید